Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218075 · ClinicalTrials.gov registry record · Phase 2
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00218075 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 200 participants.
The verdict
NCT00218075, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to examine the effectiveness of levodopa and carbidopa in treating cocaine dependent individuals. In addition, this study will examine the effects of incentive rewards for treatment compliance.
Interventions
- BEHAVIORAL Contingency Management
- DRUG Levodopa
- DRUG Carbidopa
- BEHAVIORAL Clinical Management
- BEHAVIORAL Relapse Prevention Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2000-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218075
The ClinicalTrials.gov registry entry for NCT00218075 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Contingency Management is the first listed.
NCT00218075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218075 about?
NCT00218075 is a clinical study titled "Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence". Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to examine the effectiveness of levodopa and carbidopa in treating cocaine dependent individuals. In addition, this study will exami...
What is the current status of trial NCT00218075?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2000-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00218075?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Levodopa (DRUG), Carbidopa (DRUG), Clinical Management (BEHAVIORAL), Relapse Prevention Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218075?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.